Part:BBa_K4789000:Design
miR-22-sponge
- 10INCOMPATIBLE WITH RFC[10]Illegal PstI site found at 127
- 12INCOMPATIBLE WITH RFC[12]Illegal PstI site found at 127
- 21COMPATIBLE WITH RFC[21]
- 23INCOMPATIBLE WITH RFC[23]Illegal PstI site found at 127
- 25INCOMPATIBLE WITH RFC[25]Illegal PstI site found at 127
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
miR-22-sponge was designed according to the binding site between miR-22 and lncRNA MALAT1.
Source
The miR-22-sponge were synthesized by Nanjing Genscript Biotechnology corporation.
References
1.Han Xiting,Wang Qian,Wang Yan et al. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1/microRNA-202-3p/periostin axis modulates invasion and epithelial-mesenchymal transition in human cervical cancer.[J] .J Cell Physiol, 2019, 234: 14170-14180.
2.Shen Fujin,Zheng Hongyun,Zhou Limei et al. Overexpression of MALAT1 contributes to cervical cancer progression by acting as a sponge of miR-429.[J] .J Cell Physiol, 2019, 234: 11219-11226.
3.Aftab Mehreen,Poojary Satish S,Seshan Vaishnavi et al. Urine miRNA signature as a potential non-invasive diagnostic and prognostic biomarker in cervical cancer.[J] .Sci Rep, 2021, 11: 10323.
4.Chen Mingming,Ma Zhao,Wu Xiaotian et al. A molecular beacon-based approach for live-cell imaging of RNA transcripts with minimal target engineering at the single-molecule level.[J] .Sci Rep, 2017, 7: 1550.
5.Kwon Ah-Young,Jeong Ju-Yeon,Park Hyun et al. miR-22-3p and miR-30e-5p Are Associated with Prognosis in Cervical Squamous Cell Carcinoma.[J] .Int J Mol Sci, 2022, 23: undefined.